213 related articles for article (PubMed ID: 10965995)
1. Increased risk of second cancers following breast cancer: role of the initial treatment.
Rubino C; de Vathaire F; Diallo I; Shamsaldin A; Lê MG
Breast Cancer Res Treat; 2000 Jun; 61(3):183-95. PubMed ID: 10965995
[TBL] [Abstract][Full Text] [Related]
2. Risks of second malignancies after breast cancer treatment: Long-term results.
Bazire L; De Rycke Y; Asselain B; Fourquet A; Kirova YM
Cancer Radiother; 2017 Feb; 21(1):10-15. PubMed ID: 28034681
[TBL] [Abstract][Full Text] [Related]
3. Risk of second non-breast cancer among patients treated with and without postoperative radiotherapy for primary breast cancer: A systematic review and meta-analysis of population-based studies including 522,739 patients.
Grantzau T; Overgaard J
Radiother Oncol; 2016 Dec; 121(3):402-413. PubMed ID: 27639892
[TBL] [Abstract][Full Text] [Related]
4. Second malignancies after adjuvant radiation therapy for early stage breast cancer: is there increased risk with addition of regional radiation to local radiation?
Hamilton SN; Tyldesley S; Li D; Olson R; McBride M
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):977-85. PubMed ID: 25832690
[TBL] [Abstract][Full Text] [Related]
5. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
6. Increased risk of colon cancer after external radiation therapy for prostate cancer.
Rapiti E; Fioretta G; Verkooijen HM; Zanetti R; Schmidlin F; Shubert H; Merglen A; Miralbell R; Bouchardy C
Int J Cancer; 2008 Sep; 123(5):1141-5. PubMed ID: 18546265
[TBL] [Abstract][Full Text] [Related]
7. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
[TBL] [Abstract][Full Text] [Related]
8. Radiation dose, chemotherapy, hormonal treatment and risk of second cancer after breast cancer treatment.
Rubino C; de Vathaire F; Shamsaldin A; Labbe M; Lê MG
Br J Cancer; 2003 Sep; 89(5):840-6. PubMed ID: 12942115
[TBL] [Abstract][Full Text] [Related]
9. Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment.
Rubino C; Shamsaldin A; Lê MG; Labbé M; Guinebretière JM; Chavaudra J; de Vathaire F
Breast Cancer Res Treat; 2005 Feb; 89(3):277-88. PubMed ID: 15754127
[TBL] [Abstract][Full Text] [Related]
10. Second non-germ cell malignancies in patients treated for stage I-II testicular seminoma.
Bachaud JM; Berthier F; Soulié M; Malavaud B; Plante P; Rischmann P; Chevreau C; Daly-Schveitzer N; Grosclaude P
Radiother Oncol; 1999 Feb; 50(2):191-7. PubMed ID: 10368043
[TBL] [Abstract][Full Text] [Related]
11. Secondary Breast Cancer Risk by Radiation Volume in Women With Hodgkin Lymphoma.
Conway JL; Connors JM; Tyldesley S; Savage KJ; Campbell BA; Zheng YY; Hamm J; Pickles T
Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):35-41. PubMed ID: 27979454
[TBL] [Abstract][Full Text] [Related]
12. Second malignancies in breast cancer patients following radiotherapy: a study in Florence, Italy.
Zhang W; Becciolini A; Biggeri A; Pacini P; Muirhead CR
Breast Cancer Res; 2011 Apr; 13(2):R38. PubMed ID: 21463502
[TBL] [Abstract][Full Text] [Related]
13. Angiosarcoma after radiotherapy: a cohort study of 332,163 Finnish cancer patients.
Virtanen A; Pukkala E; Auvinen A
Br J Cancer; 2007 Jul; 97(1):115-7. PubMed ID: 17519906
[TBL] [Abstract][Full Text] [Related]
14. Risk of second primary cancer among women in the Kaiser Permanente Breast Cancer Survivors Cohort.
Ramin C; Veiga LHS; Vo JB; Curtis RE; Bodelon C; Aiello Bowles EJ; Buist DSM; Weinmann S; Feigelson HS; Gierach GL; Berrington de Gonzalez A
Breast Cancer Res; 2023 May; 25(1):50. PubMed ID: 37138341
[TBL] [Abstract][Full Text] [Related]
15. Bone and Soft-Tissue Sarcoma Risk in Long-Term Survivors of Hereditary Retinoblastoma Treated With Radiation.
Kleinerman RA; Schonfeld SJ; Sigel BS; Wong-Siegel JR; Gilbert ES; Abramson DH; Seddon JM; Tucker MA; Morton LM
J Clin Oncol; 2019 Dec; 37(35):3436-3445. PubMed ID: 31622129
[TBL] [Abstract][Full Text] [Related]
16. Impact of radiotherapy in the risk of esophageal cancer as subsequent primary cancer after breast cancer.
Salminen EK; Pukkala E; Kiel KD; Hakulinen TT
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):699-704. PubMed ID: 16626885
[TBL] [Abstract][Full Text] [Related]
17. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
Schaapveld M; Aleman BM; van Eggermond AM; Janus CP; Krol AD; van der Maazen RW; Roesink J; Raemaekers JM; de Boer JP; Zijlstra JM; van Imhoff GW; Petersen EJ; Poortmans PM; Beijert M; Lybeert ML; Mulder I; Visser O; Louwman MW; Krul IM; Lugtenburg PJ; van Leeuwen FE
N Engl J Med; 2015 Dec; 373(26):2499-511. PubMed ID: 26699166
[TBL] [Abstract][Full Text] [Related]
18. Radiation dose, chemotherapy and risk of lung cancer after breast cancer treatment.
Rubino C; de Vathaire F; Diallo I; Shamsaldin A; Grimaud E; Labbe M; Contesso G; Le M
Breast Cancer Res Treat; 2002 Sep; 75(1):15-24. PubMed ID: 12500931
[TBL] [Abstract][Full Text] [Related]
19. Risk of thyroid carcinoma in a female population after radiotherapy for breast carcinoma.
Huang J; Walker R; Groome PG; Shelley W; Mackillop WJ
Cancer; 2001 Sep; 92(6):1411-8. PubMed ID: 11745217
[TBL] [Abstract][Full Text] [Related]
20. Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood.
Le Vu B; de Vathaire F; Shamsaldin A; Hawkins MM; Grimaud E; Hardiman C; Diallo I; Vassal G; Bessa E; Campbell S; Panis X; Daly-Schveitzer N; Lagrange JL; Zucker JM; Eschwège F; Chavaudra J; Lemerle J
Int J Cancer; 1998 Jul; 77(3):370-7. PubMed ID: 9663598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
